SEC Form 4 · accession 0001209191-18-014707
HERBALIFE LTD. · HLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edi Hienrich
Officer — SVP/Managing Director EMEA
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 7:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2018 | M | 19,832 | $22.94 | A | 25,625 | D | |
| Common Stock | Feb 26, 2018 | D | 5,242 | $86.30 | D | 20,383 | D | |
| Common Stock | Feb 26, 2018 | F | 7,949 | $86.30 | D | 12,434 | D | |
| Common Stock | holding | — | — | — | 1,390 | I | by Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $22.94 | Feb 26, 2018 | M | 19,832 | D | May 7, 2013 | May 7, 2020 | Common Stock | 19,832 | 0 | D |
Explanation of responses
- F1The reporting person received 6,611 shares of common stock upon the net exercise of 19,832 stock appreciation rights ("SARS"). The reporting person forfeited 5,272 shares of common stock underlying the SARS in payment of the exercise price and 7,949 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on February 26, 2018 of $86.30.